Free Trial
→ What President Trump’s Executive Order 14154 means for your money (From Stansberry Research) (Ad) Buy IDNA Stock  Free IDNA Stock Alerts

iShares Genomics Immunology and Healthcare ETF (IDNA) Institutional Ownership

iShares Genomics Immunology and Healthcare ETF logo
$20.49 +0.22 (+1.09%)
As of 02:59 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Compare

Institutional Ownership Changes (13F Filings) for iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA)

Number of
Institutional Buyers
(last 12 months)
3
Total
Institutional Inflows
(last 12 months)
$947.90K
Number of
Institutional Sellers
(last 12 months)
0
Get IDNA Insider Trade Alerts

Want to know when executives and insiders are buying or selling iShares Genomics Immunology and Healthcare ETF stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

IDNA Institutional Buying and Selling by Quarter

iShares Genomics Immunology and Healthcare ETF Major Shareholders & Ownership History

Export to Excel
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
4/22/2025 Cambridge Investment Research Advisors Inc.19,797$406K0.0%+4.0%0.374%
2/17/2025Ameriprise Financial Inc.71,832$1.63M0.0%+23.6%1.228%
1/17/2025 Avior Wealth Management LLC26,650$603K0.0%+180.5%0.456%
11/8/2024 Avior Wealth Management LLC9,500$234K0.0%N/A0.162%
2/5/2024RiverFront Investment Group LLC38,919$896K0.0%-5.2%0.643%
11/15/2023Integrated Wealth Concepts LLC56,879$1.16M0.0%-14.7%0.940%
11/7/2023RiverFront Investment Group LLC41,046$835K0.0%-3.3%0.678%
8/1/2023RiverFront Investment Group LLC42,454$991K0.0%-2.7%0.696%
7/13/2023 Cambridge Investment Research Advisors Inc.32,104$750K0.0%+6.5%0.526%
5/3/2023Integrated Wealth Concepts LLC10,876$253K0.0%N/A0.175%
4/28/2023 Janney Montgomery Scott LLC39,360$916K0.0%-3.4%0.635%
3/6/2023OLD Mission Capital LLC5,298$133K0.0%N/A0.086%
2/24/2023RiverFront Investment Group LLC45,602$1.15M0.3%+96.0%0.741%
2/13/2023 Wealthcare Advisory Partners LLC217,907$5.49M0.3%+23.9%3.543%
2/8/2023 Cambridge Investment Research Advisors Inc.29,579$745K0.0%+2.2%0.481%
2/1/2023 Janney Montgomery Scott LLC40,741$1.03M0.0%N/A0.662%
1/31/2023Westside Investment Management Inc.350$2.51M0.0%-66.7%0.006%
1/26/2023Vigilant Capital Management LLC1,000$25K0.0%N/A0.016%
1/25/2023Mayflower Financial Advisors LLC21,752$547K0.1%-6.9%0.354%
11/15/2022Flow Traders U.S. LLC11,470$303K0.0%N/A0.178%
11/9/2022Westside Investment Management Inc.1,050$21.21M0.1%+200.0%0.016%
10/17/2022 Cambridge Investment Research Advisors Inc.28,952$764K0.0%-11.5%0.449%
8/8/2022Baird Financial Group Inc.33,338$963K0.0%-19.4%0.529%
8/2/2022Triumph Capital Management18,382$160K0.1%N/A0.292%
7/13/2022 Cambridge Investment Research Advisors Inc.32,731$946K0.0%+55.4%0.515%
5/5/2022RiverFront Investment Group LLC24,394$840K0.0%+90.0%0.372%
4/21/2022Mayflower Financial Advisors LLC29,021$1M0.1%+32.6%0.427%
4/15/2022 Wealthcare Advisory Partners LLC165,681$5.71M0.3%+26.6%2.436%
4/12/2022 Wealthcare Capital Management LLC5,881$203K0.0%N/A0.086%
2/10/2022RiverFront Investment Group LLC12,842$563K0.0%N/A0.183%
2/9/2022Baird Financial Group Inc.50,228$2.20M0.0%+2.8%0.718%
2/3/2022 Cambridge Investment Research Advisors Inc.24,256$1.06M0.0%+6.5%0.342%
2/2/2022Sigma Planning Corp5,603$245K0.0%-7.6%0.079%
1/21/2022Mayflower Financial Advisors LLC21,889$959K0.1%+16.6%0.294%
1/20/2022 Parallel Advisors LLC1,168$51K0.0%+106.4%0.016%
1/19/2022Lenox Wealth Advisors LLC1,760$77K0.0%N/A0.024%
1/12/2022IFP Advisors Inc4,282$189K0.0%+7.3%0.057%
11/16/2021Captrust Financial Advisors1,137$58K0.0%+29.6%0.016%
11/16/2021Triumph Capital Management7,096$276K0.2%N/A0.098%
11/16/2021 Wealthcare Capital Management LLC5,513$280K0.0%+11.1%0.076%
A Biotech Power Move? This company is leading the charge in developing advanced antiviral therapies—watch closely! (Ad)

With a revolutionary antiviral drug, this company is in a great position to build shareholder value as this tiny biotech firm remains unaffected by tariffs and government spending cuts. Additionally, the Company has also developed a drug against HIV/AIDS, namely NV-HIV-1. The Company believes NV-HHV-1 in combination with some of the existing drugs could lead to finally achieving cures of HIV infection! In a world that has been forever changed by how quickly a virus can lead to chaos, they are developing antiviral treatments that could be a gamechanger for society while producing shareholder value.

Discover how NV-387 is possibly the most advanced drug candidate that has demonstrated both strong a
11/15/2021Flow Traders U.S. LLC19,542$991K0.0%+257.0%0.270%
11/12/2021 PSI Advisors LLC951$48K0.0%N/A0.013%
11/2/2021 Cambridge Investment Research Advisors Inc.22,773$1.16M0.0%-1.9%0.325%
10/26/2021Mayflower Financial Advisors LLC18,767$924K0.1%+15.8%0.268%
10/21/2021 Ellis Investment Partners LLC730$37K0.0%+69.8%0.010%
8/24/2021Flow Traders U.S. LLC5,474$285K0.0%-56.6%0.084%
8/16/2021 Wealthcare Capital Management LLC4,961$258K0.0%+65.4%0.076%
8/16/2021 Wealthcare Advisory Partners LLC109,762$5.71M0.4%+23.0%1.676%
8/13/2021Sigma Planning Corp5,633$293K0.0%-5.8%0.086%
8/11/2021Baird Financial Group Inc.47,101$2.45M0.0%+7.2%0.719%
8/1/2021 Patriot Financial Group Insurance Agency LLC5,432$283K0.1%+2,804.8%0.083%
5/18/2021Flow Traders U.S. LLC12,626$577K0.0%+98.6%0.204%
5/13/2021Baird Financial Group Inc.43,954$2.01M0.0%N/A0.709%
5/7/2021 Cambridge Investment Research Advisors Inc.23,367$1.07M0.0%+3.5%0.377%
5/6/2021Sigma Planning Corp5,977$273K0.0%+5.8%0.096%
5/4/2021 Outlook Wealth Advisors LLC16,352$747K0.3%+4.7%0.264%
4/30/2021 Wealthcare Capital Management LLC2,999$137K0.0%N/A0.048%
4/30/2021 Wealthcare Advisory Partners LLC89,268$4.08M0.3%+62.0%1.440%
4/22/2021James Investment Research Inc.5,247$240K0.0%-6.8%0.085%
(Data available from 1/1/2016 forward)

IDNA Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of IDNA shares?

During the previous two years, the following institutional investors and hedge funds held shares of iShares Genomics Immunology and Healthcare ETF shares: Ameriprise Financial Inc. ($1.63M), Integrated Wealth Concepts LLC ($1.16M), Janney Montgomery Scott LLC ($916K), RiverFront Investment Group LLC ($896K), and Avior Wealth Management LLC ($603K), Cambridge Investment Research Advisors Inc. ($406K).Learn more on IDNA's institutional investors.

Which institutional investors have been buying iShares Genomics Immunology and Healthcare ETF stock?

The following institutional investors have purchased iShares Genomics Immunology and Healthcare ETF stock in the last 24 months: Avior Wealth Management LLC ($26.65K), Ameriprise Financial Inc. ($13.72K), Integrated Wealth Concepts LLC ($10.88K), and Cambridge Investment Research Advisors Inc. ($2.70K).

How much institutional buying is happening at iShares Genomics Immunology and Healthcare ETF?

Institutional investors have bought a total of 53,951 shares in the last 24 months. This purchase volume represents approximately $1.25M in transactions.

Which iShares Genomics Immunology and Healthcare ETF major shareholders have been selling company stock?

The following institutional investors have sold iShares Genomics Immunology and Healthcare ETF stock in the last 24 months: Integrated Wealth Concepts LLC ($9.77K), RiverFront Investment Group LLC ($4.73K), and Janney Montgomery Scott LLC ($1.38K).

How much institutional selling is happening at iShares Genomics Immunology and Healthcare ETF?

Institutional investors have sold a total of 15,876 shares in the last 24 months. This volume of shares sold represents approximately $336.34K in transactions.


Related Companies

This page (NYSEARCA:IDNA) was last updated on 4/24/2025 by MarketBeat.com Staff
From Our Partners
Feds Just Admitted It—They Can Take Your Cash
Here’s the cold truth: If your money is sitting idle in a bank account, it’s vulnerable. That’s why thousan...
Priority Gold | Sponsored
A Biotech Power Move? This company is leading the charge in developing advanced antiviral therapies—watch closely!
With a revolutionary antiviral drug, this company is in a great position to build shareholder value as this ti...
Smallcaps Daily | Sponsored
Trump Orders 'National Digital Asset Stockpile'
‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more traction
Crypto 101 Media | Sponsored
James Altucher: Do not invest in AI unless…
I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...
Paradigm Press | Sponsored
The Exact July Date the AI Correction Will End?
AI stocks have cooled off—but Jeff Brown, the tech expert who picked Nvidia before it soared 222x, says one da...
Brownstone Research | Sponsored
Trump to redistribute trillions of dollars
Seeing how the media and other analysts are covering Trump’s actions – it’s laughable. At least it would be la...
Porter & Company | Sponsored
This Is The Moment You Betray Trump (Or Prove Them Wrong)
They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...
Colonial Metals | Sponsored
Virtually Limitless Energy?
A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discov...
Stansberry Research | Sponsored